City Clinical Hospital 1
1. Clinical features of post-covid period. Results of an international register dynamics analysis of comorbidities in SARS-CoV-2 survivors (ACTIV SARS-cov-2) (12-month follow-up)
2. Clinical features of post-covid period. Results of an international register dynamics analysis of comorbidities in SARS-CoV-2 survivors (ACTIV SARS-cov-2) (12-month follow-up)
3. Impact of vaccination status on the clinical course and outcomes of acute COVID-19 period: data from the international registry Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (AKTIV-4)
4. Impact of vaccination status on the clinical course and outcomes of acute COVID-19 period: data from the international registry Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (AKTIV-4)
5. Impact of vaccination status on the clinical course and outcomes of acute COVID-19 period: data from the international registry Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (AKTIV-4)
6. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
7. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
8. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
9. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
10. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
11. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
12. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
13. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
14. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
15. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
16. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry dynamics analysis of comorbidities in SARS-CoV-2 infection survivors
17. Peculiarities of polyvascular disease and the diagnostic significance of the ankle-brachial index in patients with coronary artery disease: results from the real-world registry KAMMA (Clinical registry on patient population with polyvascular disease in the Russian Federation and Eurasian countries)
18. Peculiarities of polyvascular disease and the diagnostic significance of the ankle-brachial index in patients with coronary artery disease: results from the real-world registry KAMMA (Clinical registry on patient population with polyvascular disease in the Russian Federation and Eurasian countries)
19. Real-world data on managing patients with coronary artery disease and multifocal atherosclerosis. Results of the 12-month international clinical registry of patients with identified multifocal atherosclerosis in the Russian Federation and Eurasian countries (KAMMA)
20. Analysis of radial artery occlusion causes and methods of its prevention after interventions using radial access. Results of the APRIORI study
21. Echo-loop of subclinical cardiovascular toxicity in women associated with HER2-positive breast cancer therapy
1